biovail corp sec widens its probe into accounting practices biovail corp said u s regulators have expanded a probe into alleged accounting irregularities and misleading financial disclosure the canadian pharmaceuticals company said it received a so called wells notice from the securities and exchange commission relating to its fiscal accounting a acquisition and how it accounts for revenue the notice indicates the sec staff intends to recommend action biovail has been dogged by concerns about its financial reporting since the sec began an inquiry into accounting and financial reporting in the sec probe covers a larger period from through the investigation relates to a warning of a revenue shortfall in the third quarter of an october truck accident involving the companys wellbutrin antidepressant and its disclosure of the accidents impact on earnings biovail said it is cooperating and noted it has the right to respond in writing before the staff makes a formal recommendation 
